Molecular Response After Concurrent Exercise With Low Glycogen
NCT ID: NCT02668445
Last Updated: 2018-10-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
14 participants
INTERVENTIONAL
2015-11-30
2016-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Muscle Glycogen Synthesis When Caffeine and Protein is Co-Ingested With Carbohydrates
NCT00975390
Effects of Acute Energy Deficit and Aerobic Exercise on Muscle Quality
NCT05203133
Carbohydrate Availability and microRNA Expression
NCT03250234
Effect of Carbohydrate-protein Co-ingestion on Short-term Recovery
NCT04859491
Effects of Protein Supplementation on Lean Body Mass Recovery From Extreme Military Training
NCT02057094
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Low carbohydrate
Subjects will eat a low carbohydrate diet
Standard meal containing low or high carbohydrate content
High carbohydrate
Subjects will eat a high carbohydrate diet
Standard meal containing low or high carbohydrate content
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Standard meal containing low or high carbohydrate content
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* BMI between 18.5 - 25 kg/m2
* Participating in regular exercise training (at least 1 exercise session, and a maximum of 3 exercise session per week)
* Used to different types of exercise (endurance, resistance and/or concurrent)
* Willing to give blood samples
* Willing to give muscle biopsies
* No use of antibiotics during the study or in the past month
* No drug use
* Suitable veins for blood withdrawal
* Registered by a general-practitioner
* Consumption of alcohol beverages is less than 21 per week
* No blood donor during the study
* No vegetarian and willing to eat meat during the experimental days
* Able to be present and participate at both test days and pre testing moments
* Not employed, or intern, or working on thesis at the department of Human Nutrition at Wageningen University
* Not participating in another scientific study (except EetMeetWeet)
* Able to participate during the experimental days en pre tests
* Able to speak Dutch
Exclusion Criteria
* Systolic blood pressure \>160 mmHg and/or diastolic blood pressure \>100 mmHg
* Use of medications known to interfere with gene expression in the muscles (i.e. statins, fenofibrate)
* Use of antithrombotic therapy (marcoumar, sintromitis).
* Diagnosed diabetes mellitus type 1 or 2
* (Chronic) injuries of the locomotor system that can interfere with the intervention
18 Years
30 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Wageningen University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Division of Human Nutrition, Wageningen University
Wageningen, Gelderland, Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NL54408.081.15
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.